Andrew K. Godwin

Department of Medical Oncology, Women's Cancer Program

Affiliated withWomen's Cancer Program University of Kansas Medical Center University of Kansas Cancer Center

Research Area

Biography

Andrew K. Godwin has not added Biography.
If you are Andrew K. Godwin and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 2	Year
Publication title Cited by 38	2010
Publication title Cited by 3	2023

Other Publications

Article	Year
Proteolytic cleavage of the CD44 adhesion molecule in multiple human tumors. The American journal of pathology\| PubMed ID: 11839564	2002
Decreased expression of retinol-binding proteins is associated with malignant transformation of the ovarian surface epithelium. DNA and cell biology\| PubMed ID: 11879576	2002
Telomere length changes in human cancer. Methods in molecular medicine\| PubMed ID: 11901508	2002
OVCA2 is downregulated and degraded during retinoid-induced apoptosis. International journal of cancer. Journal international du cancer\| PubMed ID: 11979432	2002
Molecular events associated with dysplastic morphologic transformation and initiation of ovarian tumorigenicity. Cancer\| PubMed ID: 12015763	2002
Comparison of DNA- and RNA-based methods for detection of truncating BRCA1 mutations. Human mutation\| PubMed ID: 12112659	2002
Gamma-synuclein promotes cancer cell survival and inhibits stress- and chemotherapy drug-induced apoptosis by modulating MAPK pathways. The Journal of biological chemistry\| PubMed ID: 12121974	2002
Elevated JNK activation contributes to the pathogenesis of human brain tumors. Oncogene\| PubMed ID: 12140754	2002
Ras/MAPK pathway confers basement membrane dependence upon endoderm differentiation of embryonic carcinoma cells. The Journal of biological chemistry\| PubMed ID: 12145292	2002
DNA array-based method for detection of large rearrangements in the BRCA1 gene. Genes, chromosomes & cancer\| PubMed ID: 12353265	2002
Dynamic alterations of the extracellular environment of ovarian surface epithelial cells in premalignant transformation, tumorigenicity, and metastasis. Cancer\| PubMed ID: 12365030	2002
Hypomethylation of the synuclein gamma gene CpG island promotes its aberrant expression in breast carcinoma and ovarian carcinoma. Cancer research\| PubMed ID: 12566312	2003
Microarrays in cancer: research and applications. BioTechniques\| PubMed ID: 12664679	2003
Communication of BRCA1 and BRCA2 results to at-risk relatives: a cancer risk assessment program's experience. American journal of medical genetics. Part C, Seminars in medical genetics\| PubMed ID: 12704633	2003
Expression of constitutively activated EGFRvIII in non-small cell lung cancer. Cancer science\| PubMed ID: 12708474	2003
Parkin, a gene implicated in autosomal recessive juvenile parkinsonism, is a candidate tumor suppressor gene on chromosome 6q25-q27. Proceedings of the National Academy of Sciences of the United States of America\| PubMed ID: 12719539	2003
Response markers and the molecular mechanisms of action of Gleevec in gastrointestinal stromal tumors. Molecular cancer therapeutics\| PubMed ID: 12939459	2003
Anomalous expression of epithelial differentiation-determining GATA factors in ovarian tumorigenesis. Cancer research\| PubMed ID: 12941822	2003
The BCSC-1 locus at chromosome 11q23-q24 is a candidate tumor suppressor gene. Proceedings of the National Academy of Sciences of the United States of America\| PubMed ID: 14504409	2003
Regulation of BRCC, a holoenzyme complex containing BRCA1 and BRCA2, by a signalosome-like subunit and its role in DNA repair. Molecular cell\| PubMed ID: 14636569	2003
Altered expression of the septin gene, SEPT9, in ovarian neoplasia. The Journal of pathology\| PubMed ID: 14648661	2003
Loss of surface and cyst epithelial basement membranes and preneoplastic morphologic changes in prophylactic oophorectomies. Cancer\| PubMed ID: 14669280	2003
Focus on epithelial ovarian cancer. Cancer cell\| PubMed ID: 14749123	2004
Tumor necrosis factor-alpha-induced matrix proteolytic enzyme production and basement membrane remodeling by human ovarian surface epithelial cells: molecular basis linking ovulation and can... Cancer research\| PubMed ID: 14973065	2004
Identification of a second G-C-rich promoter conserved in the human, murine and rat tumor suppressor genes HIC1. Oncogene\| PubMed ID: 15007385	2004
AKT and mTOR phosphorylation is frequently detected in ovarian cancer and can be targeted to disrupt ovarian tumor cell growth. Oncogene\| PubMed ID: 15208673	2004
Proteome changes in ovarian epithelial cells derived from women with BRCA1 mutations and family histories of cancer. Molecular & cellular proteomics : MCP\| PubMed ID: 15591324	2005
Altered gene expression in phenotypically normal renal cells from carriers of tumor suppressor gene mutations. Cancer biology & therapy\| PubMed ID: 15662135	2004
Linking transcriptional elongation and messenger RNA export to metastatic breast cancers. Cancer research\| PubMed ID: 15833825	2005
Familial cancer associated with a polymorphism in ARLTS1. The New England journal of medicine\| PubMed ID: 15843669	2005
Analysis of KIT mutations in sporadic and familial gastrointestinal stromal tumors: therapeutic implications through protein modeling. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 15897563	2005
WWOX protein expression varies among ovarian carcinoma histotypes and correlates with less favorable outcome. BMC cancer\| PubMed ID: 15982416	2005
Loss of TNF-alpha-regulated COX-2 expression in ovarian cancer cells. Oncogene\| PubMed ID: 16044148	2005
Phase II study of gefitinib in patients with relapsed or persistent ovarian or primary peritoneal carcinoma and evaluation of epidermal growth factor receptor mutations and immunohistochemic... Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 16061871	2005
Enhanced counseling for women undergoing BRCA1/2 testing: impact on subsequent decision making about risk reduction behaviors. Health education & behavior : the official publication of the Society for Public Health Education\| PubMed ID: 16148211	2005
Perception of differentiation cues by GATA factors in primitive endoderm lineage determination of mouse embryonic stem cells. Developmental biology\| PubMed ID: 16162334	2005
Molecular research directions in the management of gastrointestinal stromal tumors. Current treatment options in oncology\| PubMed ID: 16242052	2005
The joint effect of smoking and AIB1 on breast cancer risk in BRCA1 mutation carriers. Carcinogenesis\| PubMed ID: 16244359	2006
Mass spectrometric identification of serine hydrolase OVCA2 in the medulloblastoma cell line DAOY. Cancer letters\| PubMed ID: 16368187	2006
The AIB1 polyglutamine repeat does not modify breast cancer risk in BRCA1 and BRCA2 mutation carriers. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology\| PubMed ID: 16434590	2006
BRCA1-associated complexes: new targets to overcome breast cancer radiation resistance. Expert review of anticancer therapy\| PubMed ID: 16445371	2006
Molecular genetic evidence that endometriosis is a precursor of ovarian cancer. International journal of cancer. Journal international du cancer\| PubMed ID: 16506222	2006
White spot syndrome virus open reading frame 222 encodes a viral E3 ligase and mediates degradation of a host tumor suppressor via ubiquitination. Journal of virology\| PubMed ID: 16571805	2006
Intronic alterations in BRCA1 and BRCA2: effect on mRNA splicing fidelity and expression. Human mutation\| PubMed ID: 16619214	2006
Age-dependent morphological alterations of human ovaries from populations with and without BRCA mutations. Gynecologic oncology\| PubMed ID: 16698071	2006
BRCC36 is essential for ionizing radiation-induced BRCA1 phosphorylation and nuclear foci formation. Cancer research\| PubMed ID: 16707425	2006
Therapeutic effect of imatinib in gastrointestinal stromal tumors: AKT signaling dependent and independent mechanisms. Cancer research\| PubMed ID: 16707477	2006
No increased risk of breast cancer associated with alcohol consumption among carriers of BRCA1 and BRCA2 mutations ages <50 years. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology\| PubMed ID: 16896052	2006
Involvement of RHO GTPases and ERK in synuclein-gamma enhanced cancer cell motility. International journal of oncology\| PubMed ID: 17016652	2006
BRCA1 and BRCA2 mutation carriers, oral contraceptive use, and breast cancer before age 50. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology\| PubMed ID: 17021353	2006
Alterations of the tumor suppressor gene ARLTS1 in ovarian cancer. Cancer research\| PubMed ID: 17079447	2006
The molecular pathogenesis of gastrointestinal stromal tumors. Clinical colorectal cancer\| PubMed ID: 17101067	2006
Prominent expression of metalloproteinases in early stages of ovarian tumorigenesis. Molecular carcinogenesis\| PubMed ID: 17131304	2007
Nestin is expressed in the basal/myoepithelial layer of the mammary gland and is a selective marker of basal epithelial breast tumors. Cancer research\| PubMed ID: 17234757	2007
A phase II and pharmacodynamic study of gefitinib in patients with refractory or recurrent epithelial ovarian cancer. Cancer\| PubMed ID: 17330838	2007
Large genomic rearrangement in BRCA1 and BRCA2 and clinical characteristics of men with breast cancer in the United States. Clinical breast cancer\| PubMed ID: 17592676	2007
AURKA F31I polymorphism and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a consortium of investigators of modifiers of BRCA1/2 study. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology\| PubMed ID: 17627006	2007
Increased expression of the pro-protein convertase furin predicts decreased survival in ovarian cancer. Cellular oncology : the official journal of the International Society for Cellular Oncology\| PubMed ID: 17641413	2007
Expression of epiregulin and amphiregulin and K-ras mutation status predict disease control in metastatic colorectal cancer patients treated with cetuximab. Journal of clinical oncology : official journal of the American Society of Clinical Oncology\| PubMed ID: 17664471	2007
Genetic and functional analysis of CHEK2 (CHK2) variants in multiethnic cohorts. International journal of cancer. Journal international du cancer\| PubMed ID: 17721994	2007
MicroRNA-34b and MicroRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth. Cancer research\| PubMed ID: 17823410	2007
Prostate cancer risk assessment program: a 10-year update of cancer detection. The Journal of urology\| PubMed ID: 17868726	2007
Liquid chromatography mass spectrometry for quantifying plasma lysophospholipids: potential biomarkers for cancer diagnosis. Methods in enzymology\| PubMed ID: 17954226	2007
Ovca1, a candidate gene of the genetic modifier of Tp53, Mop2, affects mouse embryonic lethality. Genes, chromosomes & cancer\| PubMed ID: 18181179	2008
Allelic imbalance in BRCA1 and BRCA2 gene expression is associated with an increased breast cancer risk. Human molecular genetics\| PubMed ID: 18204050	2008
Promoter hypermethylation of the PALB2 susceptibility gene in inherited and sporadic breast and ovarian cancer. Cancer research\| PubMed ID: 18281473	2008
The differential role of L1 in ovarian carcinoma and normal ovarian surface epithelium. Cancer research\| PubMed ID: 18281486	2008
Perceived stress is associated with impaired T-cell response to HPV16 in women with cervical dysplasia. Annals of behavioral medicine : a publication of the Society of Behavioral Medicine\| PubMed ID: 18347908	2008
Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers. American journal of human genetics\| PubMed ID: 18355772	2008
Ovarian normal and tumor-associated fibroblasts retain in vivo stromal characteristics in a 3-D matrix-dependent manner. Gynecologic oncology\| PubMed ID: 18448156	2008
Insulin-like growth factor 1 receptor is a potential therapeutic target for gastrointestinal stromal tumors. Proceedings of the National Academy of Sciences of the United States of America\| PubMed ID: 18550829	2008
BRCA1 and BRCA2 mutation carriers in the Breast Cancer Family Registry: an open resource for collaborative research. Breast cancer research and treatment\| PubMed ID: 18704680	2009
The insulin-like growth factor system as a potential therapeutic target in gastrointestinal stromal tumors. Cell cycle (Georgetown, Tex.)\| PubMed ID: 18818517	2008
Molecular mechanisms of action of imatinib mesylate in human ovarian cancer: a proteomic analysis. Cancer genomics & proteomics\| PubMed ID: 18820368	2008
Standard operating procedures for serum and plasma collection: early detection research network consensus statement standard operating procedure integration working group. Journal of proteome research\| PubMed ID: 19072545	2009
No evidence that GATA3 rs570613 SNP modifies breast cancer risk. Breast cancer research and treatment\| PubMed ID: 19082709	2009
Phase II trial of single agent cetuximab in patients with persistent or recurrent epithelial ovarian or primary peritoneal carcinoma with the potential for dose escalation to rash. Gynecologic oncology\| PubMed ID: 19162309	2009
Hereditary ovarian carcinoma: heterogeneity, molecular genetics, pathology, and management. Molecular oncology\| PubMed ID: 19383374	2009
Repertoire of microRNAs in epithelial ovarian cancer as determined by next generation sequencing of small RNA cDNA libraries. PloS one\| PubMed ID: 19390579	2009
Common variation in KITLG and at 5q31.3 predisposes to testicular germ cell cancer. Nature genetics\| PubMed ID: 19483682	2009
Biological significance of prolactin in gynecologic cancers. Cancer research\| PubMed ID: 19491263	2009
Clinical and molecular characteristics of gastrointestinal stromal tumors in the pediatric and young adult population. Current oncology reports\| PubMed ID: 19508837	2009
GATA6 的损失会导致核变形和非整倍体在卵巢癌。 Molecular and cellular biology\| PubMed ID: 19581290	2009
High density DNA array analysis reveals distinct genomic profiles in a subset of gastrointestinal stromal tumors. Genes, chromosomes & cancer\| PubMed ID: 19585585	2009
Loss of GATA4 and GATA6 expression specifies ovarian cancer histological subtypes and precedes neoplastic transformation of ovarian surface epithelia. PloS one\| PubMed ID: 19649254	2009
Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers. Human molecular genetics\| PubMed ID: 19656774	2009
Gene expression signatures and response to imatinib mesylate in gastrointestinal stromal tumor. Molecular cancer therapeutics\| PubMed ID: 19671739	2009
Development and characterization of reference materials for MTHFR, SERPINA1, RET, BRCA1, and BRCA2 genetic testing. The Journal of molecular diagnostics : JMD\| PubMed ID: 19767587	2009
Prospective case-control study of serum mullerian inhibiting substance and breast cancer risk. Journal of the National Cancer Institute\| PubMed ID: 19820206	2009
Genetic variation in insulin-like growth factor signaling genes and breast cancer risk among BRCA1 and BRCA2 carriers. Breast cancer research : BCR\| PubMed ID: 19843326	2009
Regulation of miR-200 family microRNAs and ZEB transcription factors in ovarian cancer: evidence supporting a mesothelial-to-epithelial transition. Gynecologic oncology\| PubMed ID: 19854497	2010
Insulin-like growth factor binding protein-3 has dual effects on gastrointestinal stromal tumor cell viability and sensitivity to the anti-tumor effects of imatinib mesylate in vitro. Molecular cancer\| PubMed ID: 19903356	2009
Detection of treatment-induced changes in signaling pathways in gastrointestinal stromal tumors using transcriptomic data. Cancer research\| PubMed ID: 19903850	2009
Subtypes of familial breast tumours revealed by expression and copy number profiling. Breast cancer research and treatment\| PubMed ID: 19960244	2010
Altered gene expression in morphologically normal epithelial cells from heterozygous carriers of BRCA1 or BRCA2 mutations. Cancer prevention research (Philadelphia, Pa.)\| PubMed ID: 20051372	2010
Frequent downregulation of miR-34 family in human ovarian cancers. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 20145172	2010
Nuclear entry of activated MAPK is restricted in primary ovarian and mammary epithelial cells. PloS one\| PubMed ID: 20174585	2010
LYN is a mediator of epithelial-mesenchymal transition and a target of dasatinib in breast cancer. Cancer research\| PubMed ID: 20215510	2010
FOXA1 is an essential determinant of ERalpha expression and mammary ductal morphogenesis. Development (Cambridge, England)\| PubMed ID: 20501593	2010
A KRAS-variant in ovarian cancer acts as a genetic marker of cancer risk. Cancer research\| PubMed ID: 20647319	2010
A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population. Nature genetics\| PubMed ID: 20852631	2010
A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24. Nature genetics\| PubMed ID: 20852632	2010
Anti-human embryonic stem cell monoclonal antibody Hesca-2 binds to a glycan epitope commonly found on carcinomas. Stem cells and development\| PubMed ID: 20887211	2011
Role of gamma-synuclein in microtubule regulation. Experimental cell research\| PubMed ID: 20974125	2011
Protein microarray signature of autoantibody biomarkers for the early detection of breast cancer. Journal of proteome research\| PubMed ID: 20977275	2011
Association of the variants CASP8 D302H and CASP10 V410I with breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology\| PubMed ID: 20978178	2010
Upregulation of DLX5 promotes ovarian cancer cell proliferation by enhancing IRS-2-AKT signaling. Cancer research\| PubMed ID: 21045156	2010
Alteration of Differentiation Potentials by Modulating GATA Transcription Factors in Murine Embryonic Stem Cells. Stem cells international\| PubMed ID: 21048850	2010
Common genetic variants and modification of penetrance of BRCA2-associated breast cancer. PLoS genetics\| PubMed ID: 21060860	2010
Evidence for SMAD3 as a modifier of breast cancer risk in BRCA2 mutation carriers. Breast cancer research : BCR\| PubMed ID: 21114847	2010
Enhancer of zeste homolog 2 promotes the proliferation and invasion of epithelial ovarian cancer cells. Molecular cancer research : MCR\| PubMed ID: 21115743	2010
Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction. Cancer research\| PubMed ID: 21118973	2010
Novel glycan biomarkers for the detection of lung cancer. Journal of proteome research\| PubMed ID: 21214223	2011
A unique spectrum of somatic PIK3CA (p110alpha) mutations within primary endometrial carcinomas. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 21266528	2011
Contribution of large genomic BRCA1 alterations to early-onset breast cancer selected for family history and tumour morphology: a report from The Breast Cancer Family Registry. Breast cancer research : BCR\| PubMed ID: 21281505	2011
Ovarian cancer biomarker performance in prostate, lung, colorectal, and ovarian cancer screening trial specimens. Cancer prevention research (Philadelphia, Pa.)\| PubMed ID: 21372036	2011
The role of KRAS rs61764370 in invasive epithelial ovarian cancer: implications for clinical testing. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 21385923	2011
A Gynecologic Oncology Group phase II trial of the protein kinase C-beta inhibitor, enzastaurin and evaluation of markers with potential predictive and prognostic value in persistent or recu... Gynecologic oncology\| PubMed ID: 21414654	2011
Nuclear envelope structural defects cause chromosomal numerical instability and aneuploidy in ovarian cancer. BMC medicine\| PubMed ID: 21439080	2011
Exploring the link between MORF4L1 and risk of breast cancer. Breast cancer research : BCR\| PubMed ID: 21466675	2011
Expression of Siglec-11 by human and chimpanzee ovarian stromal cells, with uniquely human ligands: implications for human ovarian physiology and pathology. Glycobiology\| PubMed ID: 21467073	2011
PIK3R1 (p85Î±) is somatically mutated at high frequency in primary endometrial cancer. Cancer research\| PubMed ID: 21478295	2011
Differential expressions of adhesive molecules and proteases define mechanisms of ovarian tumor cell matrix penetration/invasion. PloS one\| PubMed ID: 21526198	2011
A second independent locus within DMRT1 is associated with testicular germ cell tumor susceptibility. Human molecular genetics\| PubMed ID: 21551455	2011
Frequent genetic abnormalities of the PI3K/AKT pathway in primary ovarian cancer predict patient outcome. Genes, chromosomes & cancer\| PubMed ID: 21563232	2011
Haplotype structure in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriers. Human genetics\| PubMed ID: 21597964	2011
Novel surface targets and serum biomarkers from the ovarian cancer vasculature. Cancer biology & therapy\| PubMed ID: 21617380	2011
Loss of A-type lamin expression compromises nuclear envelope integrity in breast cancer. Chinese journal of cancer\| PubMed ID: 21627864	2011
Serum antimÃ¼llerian hormone in healthy premenopausal women. Fertility and sterility\| PubMed ID: 21704216	2011
Phase II trial of the mTOR inhibitor, temsirolimus and evaluation of circulating tumor cells and tumor biomarkers in persistent and recurrent epithelial ovarian and primary peritoneal malign... Gynecologic oncology\| PubMed ID: 21752435	2011
Wnt5a suppresses epithelial ovarian cancer by promoting cellular senescence. Cancer research\| PubMed ID: 21816908	2011
Common breast cancer susceptibility loci are associated with triple-negative breast cancer. Cancer research\| PubMed ID: 21844186	2011
Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriers. Human molecular genetics\| PubMed ID: 21890493	2011
Predisposition to cancer caused by genetic and functional defects of mammalian Atad5. PLoS genetics\| PubMed ID: 21901109	2011
An integrative genomic approach identifies p73 and p63 as activators of miR-200 microRNA family transcription. Nucleic acids research\| PubMed ID: 21917857	2012
A phase II evaluation of lapatinib in the treatment of persistent or recurrent epithelial ovarian or primary peritoneal carcinoma: A gynecologic oncology group study. Gynecologic oncology\| PubMed ID: 22037316	2012
A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor-negative breast cancer. Nature genetics\| PubMed ID: 22037553	2011
Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2. Breast cancer research : BCR\| PubMed ID: 22053997	2011
Bench to bedside and back again: personalizing treatment for patients with GIST. Molecular cancer therapeutics\| PubMed ID: 22072810	2011
Interplay between BRCA1 and RHAMM regulates epithelial apicobasal polarization and may influence risk of breast cancer. PLoS biology\| PubMed ID: 22110403	2011
Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA). Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology\| PubMed ID: 22144499	2012
The KL-VS sequence variant of Klotho and cancer risk in BRCA1 and BRCA2 mutation carriers. Breast cancer research and treatment\| PubMed ID: 22212556	2012
Ovarian cancer susceptibility alleles and risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers. Human mutation\| PubMed ID: 22253144	2012
Association between BRCA1 and BRCA2 mutations and survival in women with invasive epithelial ovarian cancer. JAMA : the journal of the American Medical Association\| PubMed ID: 22274685	2012
Progranulin (GP88) tumor tissue expression is associated with increased risk of recurrence in breast cancer patients diagnosed with estrogen receptor positive invasive ductal carcinoma. Breast cancer research : BCR\| PubMed ID: 22316048	2012
19p13.1 is a triple negative-specific breast cancer susceptibility locus. Cancer research\| PubMed ID: 22331459	2012